Bluejay Diagnostics (BJDX) Net Cash Flow (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Net Cash Flow of -$1.5 million for Q1 2026, down 165.61% sequentially from $2.3 million in Q4 2025, and down 24.84% YoY from -$2.0 million in Q1 2025.
Bluejay Diagnostics (BJDX) Net Cash Flow (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Net Cash Flow for 7 years, with the latest figure at -$1.5 million in Q1 2026.
- Quarterly Net Cash Flow fell 24.84% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $742089.0 (up 63.12% YoY) and the FY2025 annual result came in at $862930.0, down 58.78% from the prior year.
- Net Cash Flow eased to -$1.5 million in Q1 2026 per BJDX's latest filing, from $2.3 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $5.4 million in Q2 2024 and troughed at -$3.3 million in Q1 2023.
- A 5-year average of -$893980.1 and a median of -$1.5 million in 2026 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 420.98% in 2024, down 9711.14% in 2024.
- Over 5 years, Net Cash Flow stood at -$3.2 million in 2022, then grew by 9.87% to -$2.9 million in 2023, then soared by 49.32% to -$1.5 million in 2024, then jumped by 255.2% to $2.3 million in 2025, then tumbled by 165.61% to -$1.5 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$1.5 million, $2.3 million, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | 5.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.91 Mn |
| Jun 30, 2026 | 5.91 Mn |
| Mar 31, 2026 | -1.48 Mn |
| Mar 31, 2026 | -1.48 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -2.30 Mn |
| Sep 30, 2024 | -2.30 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Mar 31, 2024 | 452,653.00 |
| Mar 31, 2024 | 452,653.00 |